We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Binding Site Unveils Optilite Protein System

By LabMedica International staff writers
Posted on 09 Feb 2017

Image: The Optilite protein system (Photo courtesy of The Binding Site).

Image: The Optilite protein system (Photo courtesy of The Binding Site).

The Binding Site, which provides specialist diagnostic products to clinicians and laboratory professionals worldwide, launched its new optimized protein system, Optilite in the Middle East, at MEDLAB 2017, the world’s largest laboratory exhibition and congress in the region.

Binding Site focuses on research, development, manufacture and distribution of immunodiagnostic systems and assays for the global laboratory market. By utilizing its specialized expertise in antibody specificity technology, it has developed a broad menu of special protein assays. Binding Site gives clinicians and laboratory staff the tools to significantly improve diagnosis and management of patients with specific cancers and immune disorders.

The company has designed Optilite, a dedicated benchtop special protein analyzer, specifically for laboratory workflow optimization. Optilite’s continuous loading of samples, reagents, and consumables plus automatic re-dilution to end result enable labs to maximize test throughput while minimizing hands-on time. With a compact benchtop design, Optilite is quick to install, easy to maintain, and is equipped with full LIS connectivity and automatic barcode recognition for full traceability. Unique to Optilite is a robust antigen excess protection system with three detection methods, thereby ensuring accurate and reliable results.

Visit expo >

Gold Member

Respiratory Syncytial Virus Test

OSOM® RSV Test

POC Helicobacter Pylori Test Kit
Hepy Urease Test

Gold Member

Collection and Transport System

PurSafe Plus®

Gold Member

Immunochromatographic Assay

CRYPTO Cassette

Latest MEDLAB 2017 News

Channels

Clinical Chemistry

view channel

Image: The sensitive Raman imaging system can detect very faint signals from SERS nanoparticles that bind to tumor markers (Photo courtesy of Zhen Qiu/Michigan State University)

Compact Raman Imaging System Detects Subtle Tumor Signals

Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read more

Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics

People with diabetes often need to measure their blood glucose multiple times a day, most commonly through finger-prick blood tests or implanted sensors. These methods can be painful, inconvenient, and... Read more

POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens

Pseudomonas aeruginosa is a major cause of hospital-acquired and ventilator-associated pneumonia, particularly in lung transplant recipients and patients with structural lung disease. Its ability to form... Read more

Online Tool Detects Drug Exposure Directly from Patient Samples

Doctors often rely on patient interviews and medical records to determine what medications a person has taken, but this information is frequently incomplete. People may forget drugs they used, take over-the-counter... Read more

Molecular Diagnostics

view channel

Image: Assistant Professor Benoit Malleret (left) and Dr Hang Jing Wen (right) examine blood smears (Photo courtesy of NUS Medicine)

Blood Test Could Identify Biomarker Signature of Cerebral Malaria

Malaria remains a major cause of death and long-term disability in many low- and middle-income countries, with around 600,000 deaths reported globally each year. The most severe form, cerebral malaria,... Read more

World’s First Biomarker Blood Test to Assess MS Progression

Multiple sclerosis (MS) disease activity is caused by an abnormal immune response that results in damage to the brain and spinal cord. However, there is a lack of reliable tools to measure or predict MS progression.... Read more

Image: Neuron-derived extracellular vesicles carry many biomarker candidates for Alzheimer’s (S Chinnathambi et al., Brain Network Disorders (2025). doi.org/10.1016/j.bnd.2024.12.006)

Neuron-Derived Extracellular Vesicles Could Improve Alzheimer’s Diagnosis

Alzheimer’s disease is becoming increasingly common as global populations age, yet effective treatments for advanced stages remain limited. Early detection is therefore critical, but current diagnostic... Read more

Sample Prep Instrument to Empower Decentralized PCR Testing for Tuberculosis

Tuberculosis remains the deadliest infectious disease worldwide despite being both treatable and curable when diagnosed early. A major barrier to timely diagnosis is that PCR-based TB testing is still... Read more

Hematology

view channel

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Image: Sickle cell disease patients with higher levels of RMVs, AMVs, and EMVs were found to have more severe disease (Photo courtesy of Adobe Stock)

Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients

Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Immunology

view channel

Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response

Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more

Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs

Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read more

Blood Test Could Detect Adverse Immunotherapy Effects

Immune checkpoint inhibitors have transformed cancer treatment, but they can also trigger serious immune-related adverse events that damage healthy organs and may become life-threatening if not detected early.... Read more

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Microbiology

view channel

Image: Test strips with various uropathogenic bacterial species that are responsible for the majority of urinary tract infections (Photo courtesy of Henning Sabersky-Müssigbrodt/TUM)

New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier

Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more

Image: A digital tree built from DNA-like connections represents how scientists trace the ancestry of microbes

Breakthroughs in Microbial Analysis to Enhance Disease Prediction

Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read more

Blood-Based Diagnostic Method Could Identify Pediatric LRTIs

Lower-respiratory tract infections (LRTIs) are a leading cause of illness and death worldwide, and pneumonia is the leading infectious cause of death in children under five, claiming the lives of over... Read more

Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection

Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more

Pathology

view channel

Genetics and AI Improve Diagnosis of Aortic Stenosis

Aortic stenosis is a progressive narrowing of the aortic valve that restricts blood flow from the heart and can be fatal if left untreated. There are currently no medical therapies that can prevent or... Read more

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more

Image: Flowchart representing sample collections and small EV isolations from tissue, saliva, and plasma of HNC patients (A Jangholi et al., VIEW (2025). DOI: https://doi.org/10.1002/VIW.20250081)

Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer

Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read more

Technology

view channel

AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features

Colorectal cancer is one of the most common and deadly cancers worldwide, and accurately predicting patient survival remains a major clinical challenge. Traditional prognostic tools often rely on either... Read more

Image: The GlioExoChip chip provides a quick and minimally invasive way to monitor glioblastoma treatment response (Photo courtesy of University of Michigan)

Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer

Glioblastoma is one of the most aggressive and fatal brain cancers, with most patients surviving less than two years after diagnosis. Treatment is particularly challenging because the tumor infiltrates... Read more

Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease that is notoriously difficult to diagnose in its early stages. Early symptoms often overlap with other neurological... Read more

Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis

Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more

Industry

view channel

BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more

Abbott Acquires Cancer-Screening Company Exact Sciences

Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more

$Image: Freenome will evaluate Roche\'s forthcoming SBX technology for future development applications (Photo courtesy of Roche)$

Roche and Freenome Collaborate to Develop Cancer Screening Tests

Roche (Basel, Switzerland) and Freenome (Brisbane, CA, USA have entered into a strategic collaboration to commercialize Freenome's cancer screening technology in international markets.... Read more

Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) has formed a new artificial intelligence (AI) business unit to integrate the company's existing and planned AI applications into its Co-Dx Primer Ai platform.... Read more